Filter News
Area of Research
- (-) Computational Biology (1)
- (-) Materials (41)
- Advanced Manufacturing (6)
- Biology and Environment (20)
- Clean Energy (65)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (4)
- Isotopes (12)
- Materials for Computing (10)
- National Security (5)
- Neutron Science (19)
- Nuclear Science and Technology (15)
- Quantum information Science (3)
- Supercomputing (46)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (7)
- (-) Advanced Reactors (1)
- (-) Bioenergy (5)
- (-) Computer Science (12)
- (-) Energy Storage (8)
- (-) Frontier (1)
- (-) Isotopes (6)
- (-) Physics (11)
- (-) Polymers (5)
- (-) Sustainable Energy (4)
- Artificial Intelligence (4)
- Big Data (2)
- Biology (2)
- Biomedical (4)
- Chemical Sciences (4)
- Climate Change (2)
- Composites (3)
- Coronavirus (2)
- Critical Materials (3)
- Cybersecurity (2)
- Environment (3)
- Exascale Computing (1)
- Fusion (1)
- Grid (1)
- High-Performance Computing (1)
- ITER (1)
- Machine Learning (3)
- Materials (8)
- Materials Science (31)
- Mathematics (1)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (20)
- National Security (1)
- Neutron Science (16)
- Nuclear Energy (4)
- Quantum Computing (1)
- Quantum Science (6)
- Security (1)
- Space Exploration (1)
- Summit (2)
- Transformational Challenge Reactor (2)
- Transportation (3)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
![From left, ORNL’s Rick Lowden, Chris Bryan and Jim Kiggans were troubled that target discs of a material needed to produce Mo-99 using an accelerator could deform after irradiation and get stuck in their holder. From left, ORNL’s Rick Lowden, Chris Bryan and Jim Kiggans were troubled that target discs of a material needed to produce Mo-99 using an accelerator could deform after irradiation and get stuck in their holder.](/sites/default/files/styles/list_page_thumbnail/public/news/images/2018-P01734.jpg?itok=IbSUl9Vc)
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...